公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects | Cheng, Ya-Wen; TAI-LING CHAO ; Li, Chiao-Ling; Chiu, Mu-Fan; Kao, Han-Chieh; Wang, Sheng-Han; Pang, Yu-Hao; Lin, Chih-Hui; Tsai, Ya-Min; Lee, Wen-Hau; Tao, Mi-Hua; Ho, Tung-Ching; Wu, Ping-Yi; Jang, Li-Ting; SUI-YUAN CHANG ; Shiou-Hwei Yeh ; PEI-JER CHEN | Cell reports | 167 | 160 | |
1997 | GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Chen W.; DING-PING LIU ; JANN-TAY WANG ; Shen M.- C.; DING-SHINN CHEN | Gastroenterology | 82 | 73 | |
1997 | GB virus-C/hepatitis G virus infection in prostitutes: Possible role of sexual transmission | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.Y.; Lin R.Y.; DING-SHINN CHEN | Journal of Medical Virology | 35 | | |
1996 | GBV-C in the aetiology of fulminant hepatitis [6] | JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Mishiro S.; Yoshiba M.; Okamoto H. | Lancet | 83 | 87 | |
1996 | GBV-C/HGV infection and aplastic anaemia [7] | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 9 | 8 | |
2020 | Gender difference in the association between metabolic factors and hepatocellular carcinoma | CHI-LING CHEN ; Kuo M.-J.; Ming-Fang Yen A.; WEI-SHIUNG YANG ; JIA-HORNG KAO ; PEI-JER CHEN ; Chen, Tony Hsiu Hsi | JNCI Cancer Spectrum | 15 | 13 | |
2015 | Gender disparity in chronic hepatitis B: Mechanisms of sex hormones | Wang S.-H.; PEI-JER CHEN ; Shiou-Hwei Yeh | Journal of Gastroenterology and Hepatology (Australia) | 90 | 79 | |
2010 | Gender disparity of hepatocellular carcinoma: The roles of sex hormones | Shiou-Hwei Yeh ; PEI-JER CHEN | Oncology | 204 | 187 | |
2004 | Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus | Kim T.W.; Lee J.H.; Hung C.-F.; Peng S.; Roden R.; Wang M.-C.; Viscidi R.; Tsai Y.-C.; He L.; PEI-JER CHEN ; Boyd D.A.K.; Wu T.-C. | Journal of Virology | 158 | 142 | |
2018 | Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study | CHEN-HUA LIU ; Huang Y.-J; Yang S.-S; Chang C.-H; Yang S.-S; HSIN-YUN SUN ; CHUN-JEN LIU ; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 25 | 23 | |
2018 | Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection | CHEN-HUA LIU ; HSIN-YUN SUN ; CHUN-JEN LIU ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; Lo Y.-C; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 25 | 21 | |
2003 | Genetic alterations in hepatocellular adenomas [3] (multiple letters) | Bioulac-Sage P.; Laurent-Puig P.; Balabaud C.; Zucman-Rossi J.; Chen Y.-W.; YUNG-MING CHEN ; Shiou-Hwei Yeh ; PEI-JER CHEN | Hepatology | 8 | 9 | |
2008 | Genetic analysis and evaluation of the reassortment of influenza B viruses isolated in Taiwan during the 2004-2005 and 2006-2007 epidemics | Jian J.-W.; Lai C.-T.; Kuo C.-Y.; Kuo S.H.-S.; Hsu L.-C.; PEI-JER CHEN ; Wu H.-S.; Liu M.-T. | Virus Research | 23 | 18 | |
2008 | Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006 | Jian J.-W.; Chen G.-W.; Lai C.-T.; Hsu L.-C.; PEI-JER CHEN ; Kuo S.H.-S.; Wu H.-S.; Shih S.-R. | Journal of Clinical Microbiology | 24 | 22 | |
2006 | Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma | Shiou-Hwei Yeh ; Wu D.-C.; Tsai C.-Y.; Kuo T.-J.; Yu W.-C.; Chang Y.-S.; CHI-LING CHEN ; Chang C.-F.; Chen D.-S.; PEI-JER CHEN | Clinical Cancer Research | 54 | 49 | |
2008 | The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-α and ribavirin combined therapy for chronic hepatitis C patients | PEI-JER CHEN ; Hwang Y.; Lin C.G.-J.; Wu Y.-J.; Wu L.S.-H. | International Journal of Immunogenetics | 4 | 4 | |
2006 | Genetic mutation in hepatic adenoma: Seeing is believing | PEI-JER CHEN | Journal of Hepatology | 9 | 8 | |
2002 | Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study | King J.K.; Shiou-Hwei Yeh ; Lin M.-W.; CHUN-JEN LIU ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Hepatology | 63 | 54 | |
2006 | Genetic predisposition of responsiveness to therapy for chronic hepatitis C | Hwang Y.; Chen E.Y.; Gu Z.J.; Chuang W.-L.; Yu M.-L.; Lai M.-Y.; Chao Y.-C.; Lee C.-M.; Wang J.-H.; Dai C.-Y.; Bey M.S.-J.; Liao Y.-T.; PEI-JER CHEN ; Chen D.-S. | Pharmacogenomics | 26 | 23 | |
2006 | Genetic structural differences between responders and non-responders to interferon therapy for chronic hepatitis-B patients | PEI-JER CHEN ; Lin C.G.-J.; Lin F.Y.-F.; Chen E.; Wu L.S.-H. | Journal of Human Genetics | 6 | 3 | |